Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medications / Interventions > Bb > Beta Glucan

Beta Glucan

Beta Glucan

All Categories Medications / Interventions » Bb » Beta Glucan


  • Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

    Conditions:   B-cell Chronic Lymphocytic Leukemia;   Refractory Chronic Lymphocytic Leukemia;   Stage 0 Chronic Lymphocytic Leukemia;   Stage I Chronic Lymphocytic Leukemia;   Stage II Chronic Lymphocytic Leukemia
    Interventions:   Biological: alemtuzumab;   Biological: rituximab;   Drug: PGG beta-glucan;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Genetic: DNA analysis;   Genetic: fluorescence in situ hybridization;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Genetic: mutation analysis
    Sponsors:   Mayo Clinic;   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified April 2012
  • Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

    Conditions:   Neuroblastoma;   Bone Marrow, Sympathetic Nervous System
    Intervention:   Other: cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   Memorial Sloan-Kettering Cancer Center
    Recruiting - verified November 2011
  • The Effect of Beta-glucan in Non-Small Cell Lung Cancer

    Condition:   Non Small Cell Lung Cancer
    Intervention:   Dietary Supplement: beta-glucan
    Sponsors:   James Graham Brown Cancer Center;   James Graham Brown Cancer Center
    Recruiting - verified June 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations